| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |